For the seven non-Lynch syndrome cases where only blood-based testing was completed, no constitutional MLH1 epimutation was identified, suggesting that a somatic aetiology likely explains the MLH1/PMS2-deficiency in these cases but could not be confirmed due to insufficient tissue DNA (Fig. 1). The gene discussed is MLH1; the disease is Lynch syndrome.